pipeline

NOXXON Pharma AG is a clinical stage biotechnology company focusing on the development of Spiegelmers^® for the treatment of inflammatory diseases and hematological disorders. The company has pre-clinical Spiegelmers in additional indications. Please click on the therapeutic areas on the left or on the arrows below to learn further details about compounds in development.